Versican provides the provisional matrix for uterine spiral artery dilation and fetal growth
Versican provides the provisional matrix for uterine spiral artery dilation and fetal growth
复制标题
Versican 为子宫螺旋动脉扩张和胎儿生长提供临时基质
DOI:
10.1016/j.matbio.2022.11.004
复制
发表时间:
2023
期刊:
影响因子:
6.9
通讯作者:
Mandai Masaki
中科院分区:
文献类型:
--
作者:
Sagae Yusuke;Horie Akihito;Yanai Akihiro;Ohara Tsutomu;Nakakita Baku;Kitawaki Yoshimi;Okunomiya Asuka;Tani Hirohiko;Yamaguchi Ken;Hamanishi Junzo;Lydon John P.;Daikoku Takiko;Watanabe Hideto;Mandai Masaki
The extracellular matrix (ECM) in the endometrium plays a crucial role in mammalian pregnancy. We have shown that versican secreted from the endometrial epithelium promotes embryo implantation. Versican is a proteoglycan, a major player in the provisional matrix, and versikine, its N-terminal fragment cleaved by ADAMTS proteinases, serves as a bioactive molecule. Here, since versican expression in the placenta was dynamically altered in humans and mice, we investigated the role of versican in pregnancy using uterine-specificVcandeletion mice (uKO mice) and ADAMTS-resistant versican expressing mice (V1R mice). uKO mice exhibited insufficient spiral artery dilation, followed by fetal growth restriction and maternal hypertension. Further analysis revealed impaired proliferation of tissue-resident natural killer cells required for spiral artery dilation. V1R mice showed the same results as the control, eliminating the involvement of versikine. Our results provide a new concept that versican, one factor of ECM, contributes to placentation and following fetal growth.